Abstract The silent pandemic caused by antimicrobial resistance (AMR) requires innovative therapeutic approaches. Human monoclonal antibodies (mAbs), which are among the most transformative, safe and effective drugs in oncology and autoimmunity, are rarely used for infectious diseases and not yet used for AMR.
Anna Kabanova +29 more
openaire +1 more source
Clonal Dissemination of Pandrug-Resistant <i>Klebsiella pneumoniae</i> ST392KL27 in a Tertiary Care Hospital in Mexico. [PDF]
Cortés-Ortíz IA +10 more
europepmc +1 more source
DeNIS collaboration: setting the future research agenda. [PDF]
Folgori, L +4 more
core +1 more source
Corrigendum: Isolation and Characterization of a Novel Myophage Abp9 Against Pandrug Resistant Acinetobacater baumannii. [PDF]
Jiang L +8 more
europepmc +1 more source
Molecular Epidemiology and MLST-Based Typing of Pandrug-Resistant <i>Acinetobacter baumannii</i> Clinical Isolates in Iraq: A Cross-Sectional Study. [PDF]
Jubair HH, Mezher MJ, Mayea NA.
europepmc +1 more source
Isolation and Characterization of Three Lytic Bacteriophages to Overcome Multidrug-, Extensive Drug-, and Pandrug-Resistant <i>Pseudomonas aeruginosa</i>. [PDF]
Saleh MM, Sabbah MA, Zedan ZK.
europepmc +1 more source
Long-term outcome in a person with pandrug-resistant HIV: the added value of a multidisciplinary approach. [PDF]
Clemente T +7 more
europepmc +1 more source
Carbapenem-Resistant influences the outcome of early infections in liver transplant recipients [PDF]
core +1 more source
ICD-9-CM coding for multidrug resistant infection correlates poorly with microbiologically confirmed multidrug resistant infection [PDF]
Babcock, Hilary M +4 more
core +2 more sources

